Grünenthal returns to debt markets for revolver after HY bond debut
Grünenthal, the German opioid maker, has signed a €400m revolving credit facility, less than a month after making its postponed debut in the high yield bond market.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article: